Vicarious Surgical (RBOT) Interest & Investment Income (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Interest & Investment Income came in at $8000.0 in Q3 2025, down 99.0% year-on-year from $802000.0 in Q3 2024, and down 96.97% on a QoQ basis from $264000.0 in Q2 2025.
Vicarious Surgical (RBOT) Interest & Investment Income (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Interest & Investment Income data on file, last reported at $8000.0 in Q3 2025.
- On a quarterly basis, Interest & Investment Income fell 99.0% year-over-year to $8000.0 in Q3 2025; TTM through Sep 2025 was $1.3 million, a 64.16% decrease from a year earlier, with the FY2024 full-year figure at $3.3 million, down 25.74% from the prior year.
- Interest & Investment Income for Q3 2025 stood at $8000.0, down from $264000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for RBOT reached as high as $1.0 million in Q2 2023 and fell as low as -$1000.0 in Q3 2021.
- Historically, Interest & Investment Income has averaged $446473.7 across 5 years, with a median of $446000.0 in 2025.
- Across the five-year window, Interest & Investment Income slumped 200.0% in 2021 and soared 49500.0% in 2022, its largest moves.
- Year by year, Interest & Investment Income stood at $19000.0 in 2021, then jumped by 4278.95% to $832000.0 in 2022, then grew by 16.11% to $966000.0 in 2023, then tumbled by 38.51% to $594000.0 in 2024, then tumbled by 98.65% to $8000.0 in 2025.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $8000.0 in Q3 2025, $264000.0 in Q2 2025, and $446000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Vicarious Surgical | 625,212.51 | -9.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 264,000.00 |
| Mar 31, 2025 | 446,000.00 |
| Dec 31, 2024 | 594,000.00 |
| Sep 30, 2024 | 802,000.00 |
| Jun 30, 2024 | 918,000.00 |
| Mar 31, 2024 | 975,000.00 |
| Dec 31, 2023 | 966,000.00 |
| Sep 30, 2023 | 946,000.00 |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 65,000.00 |
| Dec 31, 2022 | 832,000.00 |
| Sep 30, 2022 | 494,000.00 |
| Jun 30, 2022 | 101,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 19,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | -1,000.00 |